Omega Therapeutics (OMGAQ) News Today $0.06 0.00 (-4.30%) As of 03:40 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock OMGAQ Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Omega Therapeutics Inc (OMGAQ)March 5, 2025 | investing.comHuge distressed drugmaker seeks sale in Chapter 11 bankruptcyFebruary 27, 2025 | msn.comIntrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & ImmunologyFebruary 19, 2025 | markets.businessinsider.comOmega Therapeutics secures $9.8M in DIP financingFebruary 14, 2025 | msn.comOmega Therapeutics announces board reshuffle and new directorJanuary 29, 2025 | msn.comOmega Therapeutics stock hits 52-week low at $0.52January 21, 2025 | msn.comOmega Therapeutics Appoints New Director Ravi MehrotraDecember 6, 2024 | tipranks.comOmega Therapeutics Reports Third Quarter 2024 ResultsNovember 19, 2024 | markets.businessinsider.comOmega Therapeutics price target lowered to $4 from $9 at Piper SandlerNovember 16, 2024 | markets.businessinsider.comPiper Sandler Remains a Buy on Omega Therapeutics (OMGA)November 16, 2024 | markets.businessinsider.comShares of Flagship-founded biotech fall as CEO departsNovember 15, 2024 | bizjournals.comOmega Therapeutics CEO Mahesh Karande to depart, Kaan Certel to succeedNovember 15, 2024 | markets.businessinsider.comOmega Therapeutics Restructures Leadership and Strategic FocusNovember 15, 2024 | markets.businessinsider.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Lowered by Raymond JamesNovember 15, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Price Target Cut to $4.00 by Analysts at Piper SandlerNovember 15, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9% - Should You Sell?November 8, 2024 | marketbeat.comOmega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific MeetingsOctober 15, 2024 | globenewswire.comOmega Therapeutics Appoints New DirectorOctober 6, 2024 | investing.comOmega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature CommunicationsSeptember 17, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Shares Up 0.8%September 10, 2024 | marketbeat.comOmega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of ResearchAugust 14, 2024 | globenewswire.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) Decreased by AnalystAugust 9, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Quotes, Forecast and News SummaryAugust 7, 2024 | benzinga.comOmega Therapeutics (NASDAQ:OMGA) Releases Earnings Results, Beats Expectations By $0.06 EPSAugust 7, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Reaffirmed by WedbushAugust 7, 2024 | marketbeat.comOmega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressAugust 6, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Trading Up 4.3%July 24, 2024 | marketbeat.comOmega Therapeutics Announces Election of Richard N. Kender to Board of DirectorsJune 24, 2024 | globenewswire.comRaymond James Begins Coverage on Omega Therapeutics (NASDAQ:OMGA)June 18, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Trading 14.5% Higher June 6, 2024 | marketbeat.comOmega Therapeutics To Participate In Two Upcoming Investor ConferencesMay 30, 2024 | globenewswire.comOmega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business OfficerMay 29, 2024 | globenewswire.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. Raised by HC Wainwright (NASDAQ:OMGA)May 15, 2024 | marketbeat.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Expected to Post Q3 2025 Earnings of ($0.29) Per ShareMay 14, 2024 | marketbeat.comBuy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial PerformanceMay 13, 2024 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Omega Therapeutics (NASDAQ:OMGA)May 13, 2024 | marketbeat.comEquities Analysts Offer Predictions for Omega Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:OMGA)May 10, 2024 | marketbeat.comOmega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersMay 8, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Receives "Buy" Rating from Chardan CapitalMay 7, 2024 | marketbeat.com4 Analysts Have This To Say About Omega TherapeuticsMay 7, 2024 | markets.businessinsider.comOmega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In LineMay 7, 2024 | finance.yahoo.comBuy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical TrialsMay 7, 2024 | markets.businessinsider.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | markets.businessinsider.comOmega Therapeutics (NASDAQ:OMGA) Rating Reiterated by WedbushMay 6, 2024 | marketbeat.comOMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024May 6, 2024 | investorplace.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | globenewswire.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Forecasted to Post Q1 2024 Earnings of ($0.38) Per ShareMay 2, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Omega Therapeutics (NASDAQ:OMGA)April 30, 2024 | marketbeat.comOmega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingApril 23, 2024 | globenewswire.comOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlApril 9, 2024 | globenewswire.com Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address OMGAQ Media Mentions By Week OMGAQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMGAQ News Sentiment▼0.001.01▲Average Medical News Sentiment OMGAQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMGAQ Articles This Week▼00▲OMGAQ Articles Average Week Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Coeptis Therapeutics News Today Tempest Therapeutics News Today NeuroSense Therapeutics News Today Cadrenal Therapeutics News Today Cognition Therapeutics News Today ALX Oncology News Today Cara Therapeutics News Today Tenax Therapeutics News Today Ovid Therapeutics News Today Cyclo Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OMGAQ) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
